| |
| |
|
| Insider
Information: |
Bradsher Neal C |
| Relationship: |
10% Owner |
| City: |
Union City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
129,185 |
|
|
Indirect Shares
|
57,363,752 |
|
|
| Direct
Value |
$1,156,585 |
|
|
|
Indirect Value
|
$486,514,725 |
|
|
| Total
Shares |
57,492,937 |
|
|
| Total
Value |
$487,671,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
60
|
50
|
|
Stock
price went up :
|
36
|
16
|
| Stock
price went down : |
24
|
34
|
| |
|
|
|
Gain/Loss Ratio : |
1.5
|
1.5
|
| Percentage
Gain/Loss : |
 6.9%
|
 -929.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-05-09 |
25,900 |
2024-05-09 |
10,768,431 |
Premium* |
|
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
612 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 23 of 25
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2014-06-16 |
4 |
B |
$2.50 |
$2,500,000 |
D/D |
1,000,000 |
13,422,262 |
3.92 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-09-07 |
4 |
B |
$41.26 |
$2,511,722 |
D/D |
60,874 |
8,973,044 |
2.45 |
% |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2010-08-13 |
4 |
OE |
$1.82 |
$2,570,094 |
D/D |
1,413,693 |
42,908 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2014-02-12 |
4 |
AS |
$69.83 |
$2,583,747 |
D/D |
(37,000) |
2,641,660 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-04-22 |
4 |
S |
$130.34 |
$2,693,997 |
D/D |
(20,669) |
9,423,422 |
0 |
% |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2021-02-05 |
4 |
B |
$4.50 |
$2,700,000 |
D/D |
600,000 |
16,776,484 |
2.45 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-02-12 |
4 |
S |
$124.22 |
$2,763,895 |
D/D |
(22,250) |
9,544,091 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-10-06 |
4 |
B |
$37.62 |
$2,832,417 |
D/D |
75,299 |
9,469,723 |
2.45 |
% |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2020-01-02 |
4 |
B |
$2.16 |
$3,000,001 |
D/D |
1,391,466 |
13,666,204 |
2.45 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-11-28 |
4 |
B |
$31.84 |
$3,088,794 |
D/D |
96,984 |
10,199,828 |
2.45 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-06-14 |
4 |
S |
$147.79 |
$3,235,862 |
D/D |
(21,895) |
9,035,737 |
0 |
% |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2014-02-11 |
4 |
AS |
$68.54 |
$3,289,886 |
D/D |
(48,000) |
2,678,660 |
0 |
- |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2019-09-11 |
4 |
B |
$1.66 |
$3,320,000 |
D/D |
2,000,000 |
11,098,267 |
2.45 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2016-02-11 |
4 |
B |
$6.01 |
$3,329,937 |
D/D |
554,066 |
0 |
2.45 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2016-02-11 |
4/A |
B |
$6.01 |
$3,329,937 |
D/D |
554,066 |
10,417,670 |
2.45 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-10-05 |
4 |
B |
$37.92 |
$3,696,399 |
D/D |
97,474 |
9,394,424 |
2.45 |
% |
|
| AST |
Asterias Biotherapeutics ... |
See Remarks Section |
– – – |
2017-10-16 |
4 |
B |
$2.60 |
$4,140,001 |
D/D |
1,592,308 |
5,292,156 |
2.44 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2024-01-05 |
4 |
B |
$28.48 |
$4,463,231 |
D/D |
156,734 |
10,764,388 |
2.45 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-09-06 |
4 |
B |
$41.43 |
$4,513,735 |
D/D |
108,944 |
8,912,170 |
2.45 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-06-16 |
4 |
S |
$148.79 |
$4,544,493 |
D/D |
(30,543) |
8,969,814 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2022-12-28 |
4 |
B |
$46.98 |
$4,697,610 |
D/D |
100,000 |
8,743,992 |
2.45 |
% |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2021-01-20 |
4 |
B |
$3.42 |
$4,999,999 |
D/D |
1,460,280 |
16,176,484 |
2.45 |
% |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2018-03-28 |
4 |
B |
$1.26 |
$5,000,000 |
D/D |
3,968,254 |
7,564,934 |
2.45 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-11-29 |
4 |
B |
$31.38 |
$5,031,358 |
D/D |
160,300 |
10,360,128 |
2.45 |
% |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2014-05-01 |
4 |
B |
$2.52 |
$5,040,000 |
D/D |
2,000,000 |
11,822,262 |
3.92 |
- |
|
612 Records found
|
|
Page 23 of 25 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
